GEMCITABINE
- Product NDC
- 63323-126
- Requested package NDC
- 63323-126-00
- 11-digit product format
- 633230126
- Labeler code
- 63323
- Product ID
- 63323-126_ce96743d-23fc-4de4-9df1-b650d64f4cbc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- GEMCITABINE
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Fresenius Kabi USA, LLC
- Application
- ANDA090799
- Marketing category
- ANDA
- Marketing start
- 2011-07-26
- Substance
- GEMCITABINE HYDROCHLORIDE
- Active strength
- 2 g/50mL
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 63323-126 | 63323-126-00 | D | Discontinued by firm | 2026-08-17 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A090799-001 | GEMCITABINE HYDROCHLORIDE | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-07-25 | |
| A090799-002 | GEMCITABINE HYDROCHLORIDE | GEMCITABINE HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-07-25 | |
| A090799-003 | GEMCITABINE HYDROCHLORIDE | GEMCITABINE HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-05-16 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A090799-001 | AP |
| A090799-002 | AP |
| A090799-003 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A090799-001 | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-07-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A090799-002 | GEMCITABINE HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-07-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A090799-003 | GEMCITABINE HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-05-16 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090799-001 | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-07-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090799-002 | GEMCITABINE HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-07-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090799-003 | GEMCITABINE HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-05-16 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090799-001 | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-07-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090799-002 | GEMCITABINE HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-07-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090799-003 | GEMCITABINE HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-05-16 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090799-001 | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-07-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090799-002 | GEMCITABINE HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-07-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090799-003 | GEMCITABINE HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-05-16 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090799-001 | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-07-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090799-002 | GEMCITABINE HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-07-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090799-003 | GEMCITABINE HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-05-16 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090799-001 | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-07-25 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090799-002 | GEMCITABINE HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-07-25 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090799-003 | GEMCITABINE HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-05-16 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090799-001 | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-07-25 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090799-002 | GEMCITABINE HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-07-25 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090799-003 | GEMCITABINE HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-05-16 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090799-001 | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-07-25 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090799-002 | GEMCITABINE HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-07-25 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090799-003 | GEMCITABINE HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-05-16 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A090799-001 | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-07-25 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A090799-002 | GEMCITABINE HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-07-25 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A090799-003 | GEMCITABINE HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-05-16 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A090799-001 | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-07-25 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A090799-002 | GEMCITABINE HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-07-25 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A090799-003 | GEMCITABINE HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-05-16 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A090799-001 | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-07-25 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A090799-002 | GEMCITABINE HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-07-25 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A090799-003 | GEMCITABINE HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-05-16 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A090799-001 | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-07-25 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A090799-002 | GEMCITABINE HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-07-25 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A090799-003 | GEMCITABINE HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-05-16 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A090799-001 | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-07-25 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A090799-002 | GEMCITABINE HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-07-25 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A090799-003 | GEMCITABINE HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-05-16 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A090799-001 | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-07-25 | 1e350fbaab3a… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A090799-001 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A090799-002 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A090799-003 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A090799-001 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A090799-002 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A090799-003 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090799-001 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090799-002 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090799-003 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A090799-001 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A090799-002 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A090799-003 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090799-001 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090799-002 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090799-003 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090799-001 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090799-002 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090799-003 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090799-001 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090799-002 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090799-003 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090799-001 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090799-002 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090799-003 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A090799-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A090799-002 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A090799-003 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A090799-001 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A090799-002 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A090799-003 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A090799-001 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A090799-002 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A090799-003 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A090799-001 | AP | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A090799-002 | AP | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A090799-003 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A090799-001 | AP | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A090799-002 | AP | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A090799-003 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A090799-001 | AP | 1 | 1e350fbaab3a… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- GEMCITABINE
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| GEMCITABINE HYDROCHLORIDE | 2 g/50mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| U347PV74IL | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| c550dd16-a5e8-44be-87f2-210c15bbb513 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 6bd95106-a412-1dad-b9cc-4cb74bfb27ce | Product name | 2 | 20230315 |
| a2b7d477-0e35-4772-8a9d-99c71e3e210b | Product name | 2 | 20190614 |
| 4c31c9b8-06d5-4f83-9eb7-cd946af7067a | Product name | 5 | 20190612 |
| a12a1c0c-65f2-45a0-8bf0-7dfc55c750b6 | Product name | 1 | 20180829 |
| d2980057-8cff-4896-979e-b4c394974cfd | Product name | 1 | 20170829 |
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
| 290f523a-f9db-9774-b5a9-e1f908ac1782 | Product name | 1 | 20150828 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| c6b65c52-69c7-df49-550a-a50c137f6218 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-126-03 | GEMCITABINE | 1 in 1 BOX | INJECTION, POWDER, LYOPHILIZED, | 1 | 19 | |
| 63323-126-03 | GEMCITABINE | 50 mL in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, LYOPHILIZED, | 50 | 19 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-126-00 | EA - Each | 63323-126 | 88292c15-15e2-4b14-a15d-2743293b6f1c | 1 | 2017-05-04 |
| 63323-126-03 | EA - Each | 63323-126 | dc33fbec-ba34-4f72-bb9c-224e0fd62f0c | 1 | 2021-03-02 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-126 | GEMCITABINE (GEMCITABINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC ] | 19 | Current NDC, Legacy NDC, 2 package rows | 20241022_c550dd16-a5e8-44be-87f2-210c15bbb513.zip |
| 63323-126 | GEMCITABINE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC ] | 7 | Current NDC, Legacy NDC | 20210129_b9347b14-7ca2-43f5-9ee8-7ba709ae6b52.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GEMCITABINE | GEMCITABINE | Fresenius Kabi USA, LLC | c550dd16-a5e8-44be-87f2-210c15bbb513 | 2024-10-14 | Warnings, Adverse reactions | 090799 ANDA090799 63323-126 |
| GEMCITABINE | GEMCITABINE | Fresenius Kabi USA, LLC | d1f3951c-d13f-4662-ad4b-ecfc07f59104 | 2021-01-20 | Warnings, Adverse reactions | 090799 ANDA090799 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1719003 | gemcitabine 1 GM Injection | PSN | c550dd16-a5e8-44be-87f2-210c15bbb513 | 19 |
| 1719005 | gemcitabine 2 GM Injection | PSN | c550dd16-a5e8-44be-87f2-210c15bbb513 | 19 |
| 1719000 | gemcitabine 200 MG Injection | PSN | c550dd16-a5e8-44be-87f2-210c15bbb513 | 19 |
| 1719003 | gemcitabine 1000 MG Injection | SCD | c550dd16-a5e8-44be-87f2-210c15bbb513 | 19 |
| 1719000 | gemcitabine 200 MG Injection | SCD | c550dd16-a5e8-44be-87f2-210c15bbb513 | 19 |
| 1719005 | gemcitabine 2000 MG Injection | SCD | c550dd16-a5e8-44be-87f2-210c15bbb513 | 19 |
| 1719003 | gemcitabine (as gemcitamine HCl) 1 GM Injection | SY | c550dd16-a5e8-44be-87f2-210c15bbb513 | 19 |
| 1719005 | gemcitabine (as gemcitamine HCl) 2 GM Injection | SY | c550dd16-a5e8-44be-87f2-210c15bbb513 | 19 |
| 1719000 | gemcitabine (as gemcitamine HCl) 200 MG Injection | SY | c550dd16-a5e8-44be-87f2-210c15bbb513 | 19 |
| 1719003 | gemcitabine 1 GM Injection | SY | c550dd16-a5e8-44be-87f2-210c15bbb513 | 19 |
| 1719005 | gemcitabine 2 GM Injection | SY | c550dd16-a5e8-44be-87f2-210c15bbb513 | 19 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 63323-126-00 | 63323012600 | 1 VIAL in 1 CARTON (63323-126-00) > 50 mL in 1 VIAL | 1 vial | 2011-05-17 | 0000-00-00 | No | No | Current |